Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 3 |
Amazon
AMZN
|
+$1.11B |
| 4 |
Airbnb
ABNB
|
+$574M |
| 5 |
NVIDIA
NVDA
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$588M |
| 2 |
NIO
NIO
|
+$539M |
| 3 |
Apple
AAPL
|
+$525M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$443M |
| 5 |
Microsoft
MSFT
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 1.94% |
| 2 | Technology | 1.9% |
| 3 | Communication Services | 1.42% |
| 4 | Financials | 1.08% |
| 5 | Healthcare | 0.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
PUT
CRISPR Therapeutics
CRSP
$5.52B
| $106M | 0.01% |
656,000
-91,700
| -12% | -$11.2M |
|
752
Bausch Health
BHC
$2.5B
| $106M | 0.01% |
3,607,383
+1,960,485
| +119% | +$59.4M |
|
753
Applied Materials
AMAT
$384B
| $106M | 0.01% |
742,098
-731,364
| -50% | -$98.1M |
|
754
PUT
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$292M
| $105M | 0.01% |
15,080
+13,447
| +823% | +$138M |
|
755
CALL
Dropbox
DBX
$7.58B
| $105M | 0.01% |
3,476,000
-637,300
| -15% | -$17.4M |
|
756
PUT
Teva Pharmaceuticals
TEVA
$43B
| $105M | 0.01% |
10,603,500
+1,160,000
| +12% | +$12.3M |
|
|
JMIA
757
PUT
Jumia Technologies
JMIA
$808M
| $104M | 0.01% |
3,444,100
-528,600
| -13% | -$16M |
|
758
Abbott
ABT
$202B
| $104M | 0.01% |
900,141
+497,925
| +124% | +$58M |
|
759
CALL
Whirlpool
WHR
$2.62B
| $104M | 0.01% |
476,400
+279,000
| +141% | +$65M |
|
|
760
Teva Pharmaceuticals
TEVA
$43B
| $104M | 0.01% |
10,487,055
+1,933,435
| +23% | +$20.5M |
|
761
Intuitive Surgical
ISRG
$132B
| $104M | 0.01% |
338,631
+110,136
| +48% | +$30.9M |
|
762
CALL
iShares Core US Aggregate Bond ETF
AGG
$138B
| $104M | 0.01% |
898,800
+757,300
| +535% | +$86.8M |
|
763
Tencent Music
TME
$14.2B
| $104M | 0.01% |
6,690,732
+1,021,521
| +18% | +$16.9M |
|
|
PRAH
764
DELISTED
PRA Health Sciences, Inc.
PRAH
| $103M | 0.01% |
+622,837
| New | +$104M |
|
765
Walmart Inc
WMT
$847B
| $102M | 0.01% |
2,178,687
-7,350,270
| -77% | -$342M |
|
766
BP
BP
$113B
| $102M | 0.01% |
3,875,576
+137,885
| +4% | +$3.62M |
|
|
WORK
767
PUT
DELISTED
Slack Technologies, Inc.
WORK
| $102M | 0.01% |
2,306,900
-1,933,800
| -46% | -$82.8M |
|
768
Vertex Pharmaceuticals
VRTX
$139B
| $102M | 0.01% |
503,547
+4,681
| +0.9% | +$979K |
|
769
PUT
Colgate-Palmolive
CL
$73.8B
| $101M | 0.01% |
1,247,200
+519,000
| +71% | +$42.4M |
|
770
CALL
Workhorse Group
WKHS
$34.1M
| $101M | 0.01% |
2,027
+672
| +50% | +$24.9M |
|
771
PUT
Best Buy
BBY
$18.4B
| $101M | 0.01% |
877,200
+204,800
| +30% | +$23.9M |
|
772
PUT
AstraZeneca
AZN
$259B
| $101M | 0.01% |
836,350
-784,400
| -48% | -$86.1M |
|
773
CALL
ProShares Short VIX Short-Term Futures ETF
SVXY
$243M
| $101M | 0.01% |
3,623,400
-109,000
| -3% | -$2.78M |
|
774
CALL
Devon Energy
DVN
$53.1B
| $100M | 0.01% |
3,428,900
+1,102,400
| +47% | +$28.5M |
|
775
CALL
Paycom
PAYC
$10.3B
| $100M | 0.01% |
275,200
+20,700
| +8% | +$7.34M |
|
Similar funds
Jeff Yass's Q2 2021 Portfolio in Review
As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2021 filing shows 1,607 new, 5,175 increased, 5,390 reduced and 1,328 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 1.9% of assets, up from 1.7% a quarter earlier, followed by Technology and Communication Services.
- Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
- Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
- Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
- Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
- Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
- Jeff Yass opened 1,607 new positions and closed 1,328 in Q2 2021.
- Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.